Cullinan Oncology: leadership appointments
Cancer-focused pharma company Cullinan Oncology has named Jeffrey Jones chief medical officer. Additionally, Anne-Marie Martin has been appointed to the company’s board of directors.
“The appointments of Dr. Jeff Jones as chief medical officer and of Dr. Annie Martin to our board of directors expands our expertise within the oncology space and brings diverse perspectives to our leadership team,” said CEO Nadim Ahmed. “With the continued advancement of our pipeline, we are excited to welcome two industry experts who will help us to optimize our upcoming opportunities in late-stage drug development across multiple modalities and indications.”